Product Description
The global robotic-assisted neurosurgery system market was valued close to $130 million in 2024. This is expected to increase over the forecast period at a CAGR of 14.5% to reach less than $330 million.
The full report suite on the global market for robotic-assisted neurosurgery systems includes two segments: capital equipment and services and maintenance revenue. Regional volumes of robotic-assisted neurosurgery procedures are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
The clinical and economic benefits of robotic systems are tied to their ability to do minimally invasive procedures. Robotic systems are revolutionizing the types of procedures that can be performed, while increasing accuracy and decreasing recovery periods. Particular benefits include better outcomes and less complications and revisions during surgery. This reduces the length of stay for patients, resulting in cost savings. However, despite the advantages offered by the robotics, its cost and training period are considered barriers of market growth. Robotic systems require a training period, often offered by the manufacturer. Also, it usually takes surgeons numerous procedures to perfect the art of using the system. Since not all surgeons will be comfortable with using a robotic system, this may limit the number of procedures performed, which will limit market growth.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET TRENDS
In 2024, North America took up the largest proportion of the overall robotic-assisted neurosurgery system market, followed by Western Europe and Asia-Pacific. It is anticipated that Asia-Pacific will experience a stronger growth rate compared to the 2 regions mentioned. Meanwhile, Africa represented the smallest segment, but is projected to have the highest compound annual growth rate (CAGR) among all other regions. All regions are expected to have a double-digit CAGR.
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET SHARE INSIGHTS
- Zimmer Biomet led the robotic-assisted neurosurgery system market globally in 2024. Zimmer Biomet offers a range of surgical robots that are a part of the ROSA® robotics portfolio. For neurosurgery, the company markets its ROSA® ONE Brain
- Synaptive Medical was the second-leading position in the global robotic-assisted neurosurgery system market. Synaptive offers its Brightmatter™ product line as well as Modus V™, a robotic microscope. The Brightmatter™ product line consists of Brightmatter™ Plan and Guide, which are used alongside the company’s Modus V™
- Medtronic occupied the third-leading position in the global robotic-assisted neurosurgery system market in 2024. The company sells its cranial robotic platform, the Stealth Autoguide™, which received U.S. Food and Drug Administration (FDA) clearance in December 2019.
GLOBAL ROBOTIC-ASSISTED NEUROSURGERY SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment Market
- Services and Maintenance Revenue Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
